Transcode Therapeutics Inc.

10/10/2024 | Press release | Distributed by Public on 10/10/2024 05:26

TransCode Therapeutics Completes Initial Dosing of First Cohort in Phase 1 Clinical Trial with TTX MC138, a microRNA Targeted Technology